MME and acute lymphoblastic leukemia: We optimized the aforementioned processing steps using a B-ALL SUP-B15 cell line for the following markers (i.e., CD19, TdT, CD34, and CD10), of which CD19/TdT were the major signatures of the leukemic cells (i.e., CLCs), Figure 4A,B.